Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization

Andrew Cameron, Claire A. Porterfield, Larry D. Byron, Jiong Wang, Zachary Pearson, Jessica L. Bohrhunter, Anthony B. Cardillo, Lindsay Ryan-Muntz, Ryan A. Sorensen, Mary T. Caserta, Steven Angeloni, Dwight J. Hardy, View ORCID ProfileMartin S. Zand, Nicole D. Pecora
doi: https://doi.org/10.1101/2020.10.05.20203976
Andrew Cameron
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire A. Porterfield
2University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry D. Byron
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiong Wang
3University of Rochester Medical Center, Department of Medicine, Nephrology, Rochester, NY, 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary Pearson
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica L. Bohrhunter
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony B. Cardillo
2University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay Ryan-Muntz
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan A. Sorensen
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary T. Caserta
4University of Rochester Medical Center, Department of Pediatrics, Rochester, NY, 14642
5University of Rochester Medical Center, Department of Medicine, Infectious Diseases, Rochester, NY, 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Angeloni
6Luminex Corporation, Austin, TX, 78727
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dwight J. Hardy
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
7University of Rochester Medical Center, Department of Microbiology and Immunology, Rochester, NY, 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin S. Zand
3University of Rochester Medical Center, Department of Medicine, Nephrology, Rochester, NY, 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin S. Zand
Nicole D. Pecora
1University of Rochester Medical Center, Clinical Microbiology, Department of Pathology and Laboratory Medicine, Rochester, NY, 14623
7University of Rochester Medical Center, Department of Microbiology and Immunology, Rochester, NY, 14642
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nicole_pecora@urmc.rochester.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The COVID-19 pandemic has highlighted the challenges inherent to the serological detection of a novel pathogen such as SARS-CoV-2. Serological tests can be used diagnostically and for surveillance, but their usefulness depends on their throughput, sensitivity and specificity. Here, we describe a multiplex fluorescent microsphere-based assay, 3Flex, that can detect antibodies to three major SARS-CoV-2 antigens—spike (S) protein, the spike ACE2 receptor-binding domain (RBD), and nucleocapsid (NP). Specificity was assessed using 213 pre-pandemic samples. Sensitivity was measured and compared to the Abbott™ ARCHITECT™ SARS-CoV-2 IgG assay using serum samples from 125 unique patients equally binned (n = 25) into 5 time intervals (≤5, 6 to 10, 11 to 15, 16 to 20, and ≥21 days from symptom onset). With samples obtained at ≤5 days from symptom onset, the 3Flex assay was more sensitive (48.0% vs. 32.0%), but the two assays performed comparably using serum obtained ≥21 days from symptom onset. A larger collection (n = 534) of discarded sera was profiled from patients (n = 140) whose COVID-19 course was characterized through chart review. This revealed the relative rise, peak (S, 23.8; RBD, 23.6; NP, 16.7; in days from symptom onset), and decline of the antibody response. Considerable interperson variation was observed with a subset of extensively sampled ICU patients. Using soluble ACE2, inhibition of antibody binding was demonstrated for S and RBD, and not for NP. Taken together, this study described the performance of an assay built on a flexible and high-throughput serological platform that proved adaptable to the emergence of a novel infectious agent.

Competing Interest Statement

S.A. is an employee of Luminex. N.P received some support for the purchase of reagents and supplies from Luminex. Luminex played no role in the design of the study, analysis of data, or writing of the manuscript.

Funding Statement

Funding from the Department of Pathology and Laboratory Medicine, University of Rochester Medical Center supported this study. This study was also partially supported by the National Institutes of Health Institute of Allergy, Immunology and Infectious Diseases grantsR21 AI138500 and R01 AI129518 (MZ, JW) and the University of Rochester Clinical and Translational Science Award UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health (MZ).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the URMC IRB.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All manuscript data is available as an attached data set.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization
Andrew Cameron, Claire A. Porterfield, Larry D. Byron, Jiong Wang, Zachary Pearson, Jessica L. Bohrhunter, Anthony B. Cardillo, Lindsay Ryan-Muntz, Ryan A. Sorensen, Mary T. Caserta, Steven Angeloni, Dwight J. Hardy, Martin S. Zand, Nicole D. Pecora
medRxiv 2020.10.05.20203976; doi: https://doi.org/10.1101/2020.10.05.20203976
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization
Andrew Cameron, Claire A. Porterfield, Larry D. Byron, Jiong Wang, Zachary Pearson, Jessica L. Bohrhunter, Anthony B. Cardillo, Lindsay Ryan-Muntz, Ryan A. Sorensen, Mary T. Caserta, Steven Angeloni, Dwight J. Hardy, Martin S. Zand, Nicole D. Pecora
medRxiv 2020.10.05.20203976; doi: https://doi.org/10.1101/2020.10.05.20203976

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (412)
  • Dentistry and Oral Medicine (69)
  • Dermatology (47)
  • Emergency Medicine (142)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4843)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (626)
  • Health Policy (318)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5326)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (93)
  • Medical Ethics (25)
  • Nephrology (75)
  • Neurology (685)
  • Nursing (42)
  • Nutrition (114)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (205)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (778)
  • Public and Global Health (1810)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)